The positive inotropic, antiarrhythmic and Na+, K+-ATPase inhibitory effects of the isoquinoline derivative BIIA.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002415:Cats; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*; D013268:Stimulation, Chemical; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D007546:Isoquinolines; C026136:HE 36; D000254:Sodium-Potassium-Exchanging ATPase